SSE Ticker: 600572

Zhejiang Conba Pharmaceutical Co., Ltd.

康恩贝

Authorized Representative: 胡季强

Board: Main A

Industry Classification: Manufacturing

A-share headline listed companies (9.16)-Stocks-Finance

Post date September 16, 2021 — 02:26 Post Lock

Kang Enbei acquires the property rights of new oral treatment drugs for 100 million yuan to enrich its large health product line

Post date September 15, 2021 — 15:27 Post Lock

Kang Enbei: On September 13th, the net repayment of financing was RMB 2.7186 million and the net repayment of RMB 4.4243 million on the previous trading day

Post date September 14, 2021 — 09:31 Post Lock

Watching the market: Brother Technology and other 2 shares stop every second-CFi.CN 中财网

Post date September 8, 2021 — 10:23 Post Lock

Keeping track of the market: Gao Zhengmin stops in seconds-CFi.CN 中财网

Post date September 8, 2021 — 10:15 Post Lock

East China traditional Chinese medicine companies’ mid-year report: Kang Enbei, ST medicinal revenue, and net profit both fell by more than 60%. Enterprises invested less than 30 million in research and development-Stock Channel-Hexun.com

Post date September 3, 2021 — 15:50 Post Lock

The company investigates Conba: More than 20 subdivided tracks to cultivate nearly 20 varieties of over 100 million large varieties to collect bid-winning products or rapidly expand the market-

Post date August 31, 2021 — 20:01 Post Lock

The net profit of the mother is cut in half, and the 100% equity of the subsidiary is sold! Can Conba Healthcare's business carry the banner?

Post date August 24, 2021 — 19:59 Post Lock

Will the parent company’s net profit be cut to sell 100% of the subsidiary’s equity, Can Conba’s health care business carry the banner? _Individual Stock Information_Market_CICC Online

Post date August 24, 2021 — 19:44 Post Lock

Owned to the mother net profit to sell 100% of the subsidiary's equity! Can Conba Healthcare's business carry the banner?

Post date August 24, 2021 — 19:38 Post Lock

Will the parent company’s net profit be cut to sell 100% of the subsidiary’s equity, Can Conba’s health care business carry the banner? _Sina Finance_Sina.com

Post date August 24, 2021 — 19:25 Post Lock

Will the parent company’s net profit be cut to sell 100% of the subsidiary’s equity, Can Conba’s health care business carry the banner? _Sina Finance_Sina.com

Post date August 24, 2021 — 19:25 Post Lock

Evening Announcements These announcements on August 12th are worth the annual report of net profit earnings per share_Sina Technology_Sina.com

Post date August 13, 2021 — 00:13 Post Lock

Evening Announcements These announcements are worth seeing on August 12

Post date August 12, 2021 — 20:55 Post Lock

Express night announcement of listed companies on August 12

Post date August 12, 2021 — 19:32 Post Lock

Kang Enbei (600572.SH): The listed transfer of 30% equity of Lanxin Microfinance Company was publicly delisted and transferred by related parties

Post date August 6, 2021 — 00:37 Post Lock

Conba (600572.SH), the main shareholder of Conba Group, has transferred 30% of the shares of Lanxin Microfinance Co., Ltd.-

Post date August 5, 2021 — 18:38 Post Lock

Conba shares: then I have been reluctant to buy the stock index pz_gold qhpz_pz advantage_huasoft capital

Post date August 4, 2021 — 02:31 Post Lock

Kang Enbei: The company's wholly-owned subsidiary drugs passed the generic drug consistency evaluation-CFi.CN 中财网

Post date August 2, 2021 — 19:16 Post Lock

Buchang Pharmaceutical ranks among the top 100 Chinese medicine companies in 2020, and its biomedical business has achieved fruitful results-stock-financial circles

Post date July 26, 2021 — 11:13 Post Lock